IPO Landscape Favorable for Orthopedic Players
Three companies – Treace Medical Concepts, Bioventus and Paragon 28 – made the leap in 2021. Market conditions could induce more to go public in 2022. Oct 20, 2021
We've found 286 results
Episurf Developing MTP Joint Implant
The company targets the filing of an FDA 510(k) application for the Episealer MTP system late 2022 or first half of 2023. Sep 28, 2021
Royal Biologics Takes Diverse Approach to Autologous Live Cell Therapy
While autologous live cell therapies are not new, Royal Biologics is creating a unique value proposition through its growing ALC portfolio. Sep 22, 2021
Orthopedic Market Nears Normalization as 2021 Winds Down
The orthopedic market outperformed expectations in the first half of 2021, given gaps in vaccine coverage and the surging delta variant. Sep 08, 2021
LimaCorporate Delivers Strong Top-Line Performance in First Half
In 2Q21, the company regained much of its pre-pandemic growth momentum except for a lagging recovery in Italy. Aug 26, 2021
Medtronic Opens Fiscal Year With Spine Share Gains
The company's FY 1Q22 saw double-digit growth in its spine business, driven by strength in biologics and recovering surgical volumes. Aug 25, 2021
Executives Talk the Past, Present and Future of Robotics
Technology updates, the competitive landscape and surgeon and patient interest are pushing orthopedic companies to speed robotic iterations and innovations. Aug 18, 2021
What Orthopedic Executives Said About 2Q21
Second-quarter commentary from ortho executives focused on acquisitions, knee replacement sales performance and enabling technology’s impact. Aug 18, 2021
Amplitude Surgical Looks to Rebuild Momentum
The company closed its 2021 fiscal year up high single digits compared to 2020 but is still well below historical norms. Aug 16, 2021
OrthoPediatrics Organic Growth Driven by Market Share Gains
The company's revenue grew double-digits in 2Q21 on the strength of share gains instead of recapturing backlogged procedures. Aug 11, 2021
